Drug Type Small molecule drug |
Synonyms oxaloacetic acid, BenaGene |
Target |
Action agonists |
Mechanism AMPK agonists(AMP活化蛋白激酶激动剂) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC4H4O5 |
InChIKeyKHPXUQMNIQBQEV-UHFFFAOYSA-N |
CAS Registry328-42-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Oxaloacetic Acid | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Phase 3 | United States | 01 Dec 2012 | |
Amyotrophic Lateral Sclerosis | Phase 1 | United States | 17 Mar 2020 |
Phase 2/3 | 33 | (Oxaloacetate (OAA)) | hboanroqhh(jglkqtoelz) = lfgntaicer pzopikhdfa (pvvrdvrpzw, 6.7) View more | - | 17 Mar 2016 | ||
Placebo (Placebo) | hboanroqhh(jglkqtoelz) = licoyyfmvc pzopikhdfa (pvvrdvrpzw, 10.8) View more |